Maquet Cardiovascular, LLC Maquet Getinge-BEQ-TOP 32100 ADULT CUSTOM PAC Material:701054438 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Maquet Getinge-BEQ-TOP 32100 ADULT CUSTOM PAC Material:701054438
Brand
Maquet Cardiovascular, LLC
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Batch Numbers: 3000043291 3000044425 3000046811 3000047912 3000052203 3000053795 3000059174 3000062478 3000066197 3000067469 3000070703 3000074122 3000075896
Maquet Cardiovascular, LLC is recalling Maquet Getinge-BEQ-TOP 32100 ADULT CUSTOM PAC Material:701054438 due to Custom Tubing Sets for Extracorporeal Circulation (ECC)-During sterilization, the closed stopcock/non-vented cap configuration may prevent the flow of. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Custom Tubing Sets for Extracorporeal Circulation (ECC)-During sterilization, the closed stopcock/non-vented cap configuration may prevent the flow of humidity/ethylene oxide gas into the fluid-path between the closed port and the non-vented cap therefore the Sterility Assurance Level (SAL) of the stopcock ports cannot be assured
Recommended Action
Per FDA guidance
Maquet Getinge issued recall notification letter on April 18, 2019 via FedEx 2-day delivery identifies issue, health risk and action to take: quarantine and return to Maquet/Getinge recalled product. Complete response form and return to acknowledge this recall. Questions contact Getinge Customer Service at 1 888 627 8383 (press option 2, then option 2) between the hours of 8 AM and 6 PM Eastern Standard Time. On 3/26/20 firm expanded recall to include an additional lot for one consignee,product: "BEQ TOP 25003 3/8 3/8 up to 7 lpm", item number 701063255R02, lot 3000087051.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026